Abiopharma

🔍 TERNES DONAVON P (Executive)

Company: PROVIDENT FINANCIAL HOLDINGS INC (PROV)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Sold 1,346 shares of Common Stock, PAR value $0.01 at $18.02 per share (Direct)
  Date: 2026-08-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 219,909.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock, PAR value $0.01 (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 20,750.00

Footnotes:

• F1: Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock.
• F2: The ownership of 219,909 shares include 9,000 shares of restricted stock under the Provident 2022 Equity Incentive Plan, which vests on May 23, 2028, and 47,500 shares owned by the reporting person's spouse.